eDruginfo.com
Wolters Kluwer | Lippencott Williams & Wilkins
Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



atazanavir
Reyataz Pharmaceutical company:
Bristol-Myers Squibb Co.
www.reyataz.com

NEW INDICATION & DOSAGE
In combination with other antiretrovirals, to treat HIV-1 infection in pediatric patients; dosage is based on body weight--
Children ages 6 to 18: Treatment-naïve patients—for patients weighing 15 to 25 kg, give 150 mg atazanavir with 80 mg ritonavir; for patients weighing 25 to 32 kg, give 200 mg atazanavir with 100 mg ritonavir; for patients weighing 32 to 39 kg, give 250 mg atazanavir with 100 mg ritonavir; for patients weighing more than 39 kg, give 300 mg atazanavir with 100 mg ritonavir
   Treatment-experienced patients—for patients weighing 25 to 32 kg, give 200 mg atazanavir with 100 mg ritonavir; for patients weighing 32 to 39 kg, give 250 mg atazanavir with 100 mg ritonavir; for patients weighing more than 39 kg, give 300 mg atazanavir with 100 mg ritonavir.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins